Dual-stage Acting Dendrimeric Nanoparticle for Deepened Chemotherapeutic Drug Delivery to Tumor Cells
Advanced Pharmaceutical Bulletin · 10.10.2024 · 14 (3) · 634-645
DOI: 10.34172/apb.2024.054 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Pharmaceutical Bulletin, online erschienen am 29.06.2024. Verfasst von Mohammad Shahpouri und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Purpose
We report on the design of hypoxia-induced dual-stage acting dendrimeric nanoparticles (NPs) for selective delivery of two chemotherapeutic model drugs doxorubicin (DOX) and tirapazamin (TPZ) for deepened drug delivery into hypoxic tumors in vitro.
Methods
PAMAM G5 dendrimers were crosslinked with a hypoxic azo linker, attached to a mPEG to form a detachable corona on the dendrimer surface (PAP NPs). NPs were characterized by Zeta sizer, transmission electron microscope (TEM), Fourier transforms infrared (FTIR) and drug release kinetics. The anti-cancer performance of PAPs was evaluated by numerous tests in 2D and 3D cultured MDA-MB-231 breast cancer cells.
Results
MTT assay showed a significant difference between PAP and PAMAMG5 in terms of biocompatibility, and the effect of PAP@DOX was significantly greater than free DOX in hypoxic conditions. The results of DAPI and Annexin V-FITC/PI cell staining also confirmed uniform drug penetration as validated by induction of 90% cell apoptosis in spheroids and a high level of PAP@DOX-induced ROS generation under hypoxia conditions. Mechanistically, PAP@DOX significantly reduced the expression of mTOR, and Notch1, while the expression of Bax and Caspase3 was considerably unregulated, compared to the controls. Importantly, hypoxia-responsive disintegration and hypoxia-induced activation of HAP drug were synergized to promote deep and homogenous HAP distribution in whole microtumor regions to efficiently eliminate residual tumor cells.
Conclusion
Our results indicate the safety and high therapeutic potential of PAP system for targeted drug delivery of chemotherapeutics in particular HAPs which show maximum anti-cancer activity against hypoxic solid tumors.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Biotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
- Department of Biology, Faculty of Science, Malayer University, Malayer, Iran.
- Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
- Nano Drug Delivery Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
- Student Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran.
ORCID-Profile: Mohammad Shahpouri, Rana Jahanban-Esfahlan
Zitieren
APA
Shahpouri, M., Adili-Aghdam, M. A., Mahmudi, H., Ghiasvand, S., Dadashi, H., Salemi, A., Alimohammadvand, S., Roshangar, L., Barzegari, A., Jaymand, M., & Jahanban-Esfahlan, R. (2024). Dual-stage Acting Dendrimeric Nanoparticle for Deepened Chemotherapeutic Drug Delivery to Tumor Cells. Advanced Pharmaceutical Bulletin, 14(3), 634-645. https://doi.org/10.34172/apb.2024.054
Vancouver
Shahpouri M, Adili-Aghdam MA, Mahmudi H, Ghiasvand S, Dadashi H, Salemi A, et al. Dual-stage Acting Dendrimeric Nanoparticle for Deepened Chemotherapeutic Drug Delivery to Tumor Cells. Advanced Pharmaceutical Bulletin. 2024;14(3):634-645. doi:10.34172/apb.2024.054
BibTeX
@article{Shahpouri2024,
author = {Shahpouri, Mohammad and Adili-Aghdam, Mohammad Amin and Mahmudi, Hossein and Ghiasvand, Saeedeh and Dadashi, Hamed and Salemi, Aysan and Alimohammadvand, Sajjad and Roshangar, Leila and Barzegari, Abolfazl and Jaymand, Mehdi and Jahanban-Esfahlan, Rana},
title = {Dual-stage Acting Dendrimeric Nanoparticle for Deepened Chemotherapeutic Drug Delivery to Tumor Cells},
journal = {Advanced Pharmaceutical Bulletin},
year = {2024},
volume = {14},
number = {3},
pages = {634--645},
doi = {10.34172/apb.2024.054}
}
EUVIMED